248 related articles for article (PubMed ID: 9378378)
21. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus.
Van Laethem JL; Peny MO; Salmon I; Cremer M; Devière J
Gut; 2000 Apr; 46(4):574-7. PubMed ID: 10716690
[TBL] [Abstract][Full Text] [Related]
22. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
Jankowski JA; Anderson M
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
[TBL] [Abstract][Full Text] [Related]
23. Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus.
Leedham SJ; Preston SL; McDonald SA; Elia G; Bhandari P; Poller D; Harrison R; Novelli MR; Jankowski JA; Wright NA
Gut; 2008 Aug; 57(8):1041-8. PubMed ID: 18305067
[TBL] [Abstract][Full Text] [Related]
24. Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus.
Montes CG; Brandalise NA; Deliza R; Novais de Magalhães AF; Ferraz JG
Gastrointest Endosc; 1999 Aug; 50(2):173-7. PubMed ID: 10425408
[TBL] [Abstract][Full Text] [Related]
25. Barrett's oesophagus: Current controversies.
Amadi C; Gatenby P
World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
[TBL] [Abstract][Full Text] [Related]
26. The histopathology of treated Barrett's esophagus: squamous reepithelialization after acid suppression and laser and photodynamic therapy.
Biddlestone LR; Barham CP; Wilkinson SP; Barr H; Shepherd NA
Am J Surg Pathol; 1998 Feb; 22(2):239-45. PubMed ID: 9500226
[TBL] [Abstract][Full Text] [Related]
27. Ablation of Barrett's oesophagus: towards improved outcomes for oesophageal cancer?
Mayne GC; Bright T; Hussey DJ; Watson DI
ANZ J Surg; 2012 Sep; 82(9):592-8. PubMed ID: 22901306
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-143 and -205 expression in neosquamous esophageal epithelium following Argon plasma ablation of Barrett's esophagus.
Dijckmeester WA; Wijnhoven BP; Watson DI; Leong MP; Michael MZ; Mayne GC; Bright T; Astill D; Hussey DJ
J Gastrointest Surg; 2009 May; 13(5):846-53. PubMed ID: 19190970
[TBL] [Abstract][Full Text] [Related]
29. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
30. Maximal acid reflux control for Barrett's oesophagus: feasible and effective.
Srinivasan R; Katz PO; Ramakrishnan A; Katzka DA; Vela MF; Castell DO
Aliment Pharmacol Ther; 2001 Apr; 15(4):519-24. PubMed ID: 11284781
[TBL] [Abstract][Full Text] [Related]
31. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
Shearer C; Going J; Neilson L; Mackay C; Stuart RC
Histopathology; 2005 Sep; 47(3):268-75. PubMed ID: 16115227
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery.
Salo JA; Salminen JT; Kiviluoto TA; Nemlander AT; Rämö OJ; Färkkilä MA; Kivilaakso EO; Mattila SP
Ann Surg; 1998 Jan; 227(1):40-4. PubMed ID: 9445108
[TBL] [Abstract][Full Text] [Related]
33. Experimental columnar metaplasia in the canine oesophagus.
Gillen P; Keeling P; Byrne PJ; West AB; Hennessy TP
Br J Surg; 1988 Feb; 75(2):113-5. PubMed ID: 3349294
[TBL] [Abstract][Full Text] [Related]
34. Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy.
Gore S; Healey CJ; Sutton R; Eyre-Brook IA; Gear MW; Shepherd NA; Wilkinson SP
Aliment Pharmacol Ther; 1993 Dec; 7(6):623-8. PubMed ID: 8161668
[TBL] [Abstract][Full Text] [Related]
35. Barrett's oesophagus: the new endoscopic modalities have a future.
Deviere J
Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i33-7. PubMed ID: 15711006
[TBL] [Abstract][Full Text] [Related]
36. Predictors of recurrent specialized intestinal metaplasia after complete laser ablation.
Fisher RS; Bromer MQ; Thomas RM; Cohen S; Krevsky B; Horwitz B; Glazier KD; Das K; Das KM
Am J Gastroenterol; 2003 Sep; 98(9):1945-51. PubMed ID: 14499770
[TBL] [Abstract][Full Text] [Related]
37. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
38. Barrett's oesophagus.
Navaratnam RM; Winslet MC
Postgrad Med J; 1998 Nov; 74(877):653-7. PubMed ID: 10197195
[TBL] [Abstract][Full Text] [Related]
39. Prospective randomized trial of argon plasma coagulation ablation versus endoscopic surveillance of Barrett's esophagus in patients treated with antisecretory medication.
Bright T; Watson DI; Tam W; Game PA; Ackroyd R; Devitt PG; Schoeman MN
Dig Dis Sci; 2009 Dec; 54(12):2606-11. PubMed ID: 19101798
[TBL] [Abstract][Full Text] [Related]
40. Methylation panel is a diagnostic biomarker for Barrett's oesophagus in endoscopic biopsies and non-endoscopic cytology specimens.
Chettouh H; Mowforth O; Galeano-Dalmau N; Bezawada N; Ross-Innes C; MacRae S; Debiram-Beecham I; O'Donovan M; Fitzgerald RC
Gut; 2018 Nov; 67(11):1942-1949. PubMed ID: 29084829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
